Vilin Bio Med Limited — Board Meeting, 10-01-2026: Outcome of Board Meeting
10-01-2026 | 08:48 pm
10-01-2026 | 08:48 pm
Vilin Bio Med's board approved increasing authorized share capital to ₹25 Cr and a ₹3.38 Cr preferential issue of 13 lakh shares at ₹26/share. The company is actively identifying acquisition targets. An Independent Director resigned. An Extra-ordinary General Meeting is set for February 9.
No comments yet. Be the first to comment!
